Related references
Note: Only part of the references are listed.Significance of 18F-Fluorodeoxyglucose (FDG) Uptake in Response to Chemoradiotherapy for Pancreatic Cancer
Hiroshi Kurahara et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
Meta-analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer
E. Versteijne et al.
BRITISH JOURNAL OF SURGERY (2018)
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
T. Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Neoadjuvant chemoradiotherapy of pancreatic cancer induces a favorable immunogenic tumor microenvironment associated with increased major histocompatibility complex class I-related chain A/B expression
Takashi Murakami et al.
JOURNAL OF SURGICAL ONCOLOGY (2017)
Prognosis of locally advanced rectal cancer can be predicted more accurately using pre-and post-chemoradiotherapy neutrophillymphocyte ratios in patients who received preoperative chemoradiotherapy
SooYoon Sung et al.
PLOS ONE (2017)
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy
Jinwen Shen et al.
MEDICAL SCIENCE MONITOR (2017)
Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Prognostic Significance of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Oncologic Outcomes of Esophageal Cancer: A Systematic Review and Meta-analysis
Hariruk Yodying et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
The Association Between Neutrophil/Lymphocyte Ratio and Disease Activity in Rheumatoid Arthritis and Ankylosing Spondylitis
Ridvan Mercan et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2016)
The elevated preoperative derived neutrophil-to-lymphocyte ratio predicts poor clinical outcome in breast cancer patients
Sabine Krenn-Pilko et al.
TUMOR BIOLOGY (2016)
High preoperative neutrophil-lymphocyte ratio predicts biochemical recurrence in patients with localized prostate cancer after radical prostatectomy
Hakmin Lee et al.
WORLD JOURNAL OF UROLOGY (2016)
Neoadjuvant therapy for patients with borderline resectable pancreatic cancer: A systematic review and meta-analysis of response and resection percentages
Kezhong Tang et al.
PANCREATOLOGY (2016)
Utility of pre-treatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic factors in breast cancer
C-H Koh et al.
BRITISH JOURNAL OF CANCER (2015)
Application of platelet/lymphocyte and neutrophil/lymphocyte ratios in early diagnosis and prognostic prediction in patients with resectable gastric cancer
Lian Lian et al.
CANCER BIOMARKERS (2015)
Prognostic Impact of Neutrophil-to-Lymphocyte Ratio in Patients with Advanced Low Rectal Cancer Treated with Preoperative Chemoradiotherapy
Toshiya Nagasaki et al.
DIGESTIVE SURGERY (2015)
Preoperative neutrophil to lymphocyte ratio predicts survival in patients with T1-2N0 colorectal cancer
Jun Sang Shin et al.
JOURNAL OF SURGICAL ONCOLOGY (2015)
Preoperative neutrophil/lymphocyte ratio and prognostic nutritional index predict survival in patients with non-small cell lung cancer
Katsuhiko Shimizu et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2015)
Blood Neutrophil-Lymphocyte Ratio Predicts Survival in Patients with Advanced Pancreatic Cancer Treated with Chemotherapy
Guopei Luo et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Immunological Impact of Neoadjuvant Chemoradiotherapy in Patients with Borderline Resectable Pancreatic Ductal Adenocarcinoma
Yuki Homma et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
Lola Rahib et al.
CANCER RESEARCH (2014)
Changes in the immune cell population and cell proliferation in peripheral blood after gemcitabine-based chemotherapy for pancreatic cancer
Y. Homma et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2014)
Pancreatic Adenocarcinoma, Version 2.2014 Featured Updates to the NCCN Guidelines
Margaret A. Tempero et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2014)
Prognostic importance of baseline neutrophil to lymphocyte ratio in patients with advanced papillary thyroid carcinomas
Ju-Yeon Kim et al.
ENDOCRINE (2014)
Higher Neutrophil to Lymhocyte Ratio in Patients With Metabolic Syndrome
Sevket Balta et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2013)
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
A Study of Inflammation-Based Predictors of Tumor Response to Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
Mark Krauthamer et al.
ONCOLOGY (2013)
Prognostic role of neutrophil-to-lymphocyte ratio in advanced pancreatic ductal adenocarcinoma: impact of baseline fluctuation and changes during chemotherapy
MinYuen Teo et al.
TUMORI JOURNAL (2013)
Neutrophil recruitment and function in health and inflammation
Elzbieta Kolaczkowska et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Comparison of response evaluation criteria in solid tumors with volumetric measurements for estimation of tumor burden in pancreatic adenocarcinoma and hepatocellular carcinoma
Jessemae L. Welsh et al.
AMERICAN JOURNAL OF SURGERY (2012)
Incidence of Coronary Events and Case Fatality Rate in Relation to Blood Lymphocyte and Neutrophil Counts
Samuel Adamsson Eryd et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators
Matthew H. G. Katz et al.
CANCER (2012)
The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis
M. J. M. Gooden et al.
BRITISH JOURNAL OF CANCER (2011)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Evaluation of an inflammation-based prognostic score for the identification of patients requiring postoperative adjuvant chemotherapy for stage II colorectal cancer
Yuji Toiyama et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2011)
New Response Evaluation Criteria in Solid Tumors (RECIST) Guidelines for Advanced Non-Small Cell Lung Cancer: Comparison With Original RECIST and Impact on Assessment of Tumor Response to Targeted Therapy
Mizuki Nishino et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2010)
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: N1 versus N2 TAN
Zvi G. Fridlender et al.
CANCER CELL (2009)
Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer
David Cunningham et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: A phase III trial of the National Cancer Institute of Canada clinical trials group
Malcolm J. Moore et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Share Paper
